The direct effect of GLP-1 receptor agonists on human hair follicles remains one of the most intriguing unanswered questions in dermatological pharmacology
Tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for weight management, is a dual GIP/GLP-1 receptor agonist that has transformed metabolic disease treatment
As we age, our NAD levels naturally decline
Injections are advised to circumvent potential absorption challenges in the gastrointestinal tract, particularly for those with known issues like Crohn's disease or irritable bowel syndrome, providing a more immediate replenishment compared to oral supplements, which may not be fully absorbed
Klonoff DC, Buse JB, Nielsen LL, Guan X, Bowlus CL, Holcombe JH, et al